Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Takeda Pharmaceutical Co Ltd (OTC Pink - Current Information:TKPHF)

40.70
Delayed Data
As of Jan 19
 0.00 / 0.00%
Today’s Change
39.75
Today|||52-Week Range
49.95
-1.36%
Year-to-Date
5 Expensive Drugs That Could End Up in Trump's Crosshairs
Jan 18 / MotleyFool.com - Paid Partner Content
4 Stocks in Focus as Biotech M&A Hopes Surge on Takeda-ARIAD Deal
Jan 10 / Zacks.com - Paid Partner Content
This Is the Smartest Move Valeant Pharmaceuticals Has Made in a Really Long Time
Jan 11 / MotleyFool.com - Paid Partner Content
ARIAD Pharma Stock Gains on Acquisition Deal with Takeda
Jan 10 / Zacks.com - Paid Partner Content
After ARIAD's Acquisition, These 3 Cancer Drug Stocks Could Be Next
Jan 10 / MotleyFool.com - Paid Partner Content
Why Ariad Pharmaceuticals Stock Soared Today
Jan 09 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close40.70
Today’s openn.a.
Day’s range-- - --
Volume9
Average volume (3 months)2,379
Market cap$32.2B
Dividend yield4.39%
Data as of 01/19/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-7.00%
P/E ratio--
Price/Sales2.39
Price/Book1.84

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$15.1B
Annual profit (last year)$667.6M
Net profit margin4.44%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, CEO &
Representative Director
Christophe Weber
Chief Financial &
Corporate Officer
James Kehoe
Corporate headquarters
Osaka, Osaka

Forecasts


Search for Jobs